Position
Numerai GP LLC in Theravance Biopharma, Inc.
Back to the book · All holders of TBPH
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 35.8K | $670.7K | — | — | — | 0.1% |